You just read:

Shionogi to Present New Data on Cefiderocol (S-649266), a Siderophore Cephalosporin, and S-033188, a Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza, at the 27th European Congress of Clinical Microbiology and Infectious Diseases

News provided by

Shionogi & Co., Ltd.

Apr 17, 2017, 06:00 ET